Cite
HARVARD Citation
Lu, C. et al. (n.d.). Diffuse large B-cell lymphoma: sites of extranodal involvement are a stronger prognostic indicator than number of extranodal sites in the rituximab era. Leukemia & lymphoma. 56 (7), pp. 2047-2055. [Online].